---
title: SEQENS vs Sussex Research Laboratories Inc.
slug_a: seqens
slug_b: sussex-research
site: cdmo
review_signal_gate: closed
canonical_path: /compare/seqens/sussex-research
generated_by: BioBM Editorial AI
---

# SEQENS vs Sussex Research Laboratories Inc.

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

SEQENS (seqens) is listed for cdmo. Global CDMO and specialty ingredients manufacturer with 16 production sites and 9 R&D centres offering custom development and GMP manufacturing of pharmaceutical APIs, intermediates, and specialty chemicals from preclinical to commercial scale.

Services: 8. Modalities: 1. Indications: 0. Locations: 15. Certifications: 9. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in locations (15).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Sussex Research Laboratories Inc. (sussex-research) is listed for both. Global leader in custom glycan, glycopeptide, and glycoconjugate synthesis for drug discovery and development. Offers CRO and CDMO services spanning preclinical R&D, custom carbohydrate synthesis, antibody development, and targeting ligand design with over 25 years of expertise.

Services: 8. Modalities: 1. Indications: 3. Locations: 1. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (8).

Review summary: Review summary withheld until site-level review gate opens.